Pancreatitis in A Patient with Cystic Fibrosis Taking Ivacaftor

Pancreatitis is rare in pancreatic insufficient cystic fibrosis patients. While pancreatic insufficiency has been considered irreversible until now, in the current era of new therapies with modulators of the Cystic Fibrosis Transmembrane Regulator CFTR channel, there are reports of improvement of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrocheilou, Argyri, Kaditis, Athanasios G., Loukou, Ioanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022767/
https://www.ncbi.nlm.nih.gov/pubmed/31940891
http://dx.doi.org/10.3390/children7010006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022767/
https://www.ncbi.nlm.nih.gov/pubmed/31940891
http://dx.doi.org/10.3390/children7010006

Ejemplares similares